Latest news
VTRS Q2 Deep Dive: China Growth, Pipeline Progress, and Margin Concerns Shape Outlook - TradingViewTradingView · Fri, 07 Aug 2026 21:51:10 GMTViatris Lifts 2026 Outlook After Strong Second Quarter - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 12:34:00 GMTACOG & ISSWSH continue to drive women's health forward - Contemporary OB/GYNContemporary OB/GYN · Wed, 05 Aug 2026 19:38:09 GMTJeffrey Jensen, MD, contextualizes contraceptive efficacy in modern trials - Contemporary OB/GYNContemporary OB/GYN · Tue, 04 Aug 2026 21:22:36 GMT5 FDA Decisions for Primary Care to Know from July 2026 - Patient Care OnlinePatient Care Online · Tue, 04 Aug 2026 20:15:15 GMTFDA approval of Gwyn Lo contraceptive patch - Contemporary OB/GYNContemporary OB/GYN · Mon, 03 Aug 2026 21:25:30 GMTRegulatory round-up: 3 August 2026 - The Pharma LetterThe Pharma Letter · Mon, 03 Aug 2026 08:45:47 GMTViatris (VTRS) Wins FDA Approval For Gwyn Lo Contraceptive Patch - Yahoo FinanceYahoo Finance · Sun, 02 Aug 2026 17:13:42 GMT